OrbiMed’s CVRx CVRX Stock Holding History

OrbiMed’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-723,055	Closed	-$8.84M	–	148
2021 Q4	$8.84M	Sell	723,055 -76,806	-10%	-$1.11M	0.11%	120
2021 Q3	$13.2M	Buy	799,861 +399,861	+100%	+$7.67M	0.15%	115
2021 Q2	$11.2M	Buy	+400,000	New	+$11.2M	0.11%	122

Other funds holding CVRX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

OrbiMed's CVRX Position: Q1 2022 in Review

OrbiMed sold out of CVRx (CVRX) in Q1 2022, closing a stake of 723,055 shares — an estimated $8.84M sold.

OrbiMed first reported a position in CVRX in Q2 2021 and held it in 3 quarters. The position peaked at $13.2M in Q3 2021. 55 funds tracked by Wall St. Rank hold CVRX as of Q1 2022.

OrbiMed reported no remaining CVRx position as of Q1 2022 after selling out during the quarter.
OrbiMed sold 723,055 CVRx shares in Q1 2022, an estimated $8.84M.
OrbiMed first reported a position in CVRx in Q2 2021 and held it in 3 quarters.
OrbiMed's CVRx position peaked at $13.2M in Q3 2021.
55 funds tracked by Wall St. Rank held CVRx as of Q1 2022.

Based on OrbiMed's 13F filing for Q1 2022, filed 16 May 2022.